Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
Publication
, Conference
Hernandez, AF; Bethel, MA; Bakris, GL; Merrill, P; Gustavson, SM; Katona, BG; Ohman, P; Lokhnygina, Y; Mentz, RJ; Holman, RR
Published in: DIABETOLOGIA
October 1, 2018
Duke Scholars
Published In
DIABETOLOGIA
EISSN
1432-0428
ISSN
0012-186X
Publication Date
October 1, 2018
Volume
61
Start / End Page
S38 / S38
Location
Berlin, GERMANY
Publisher
SPRINGER
Conference Name
54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
Related Subject Headings
- Endocrinology & Metabolism
- 4206 Public health
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hernandez, A. F., Bethel, M. A., Bakris, G. L., Merrill, P., Gustavson, S. M., Katona, B. G., … Holman, R. R. (2018). Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). In DIABETOLOGIA (Vol. 61, pp. S38–S38). Berlin, GERMANY: SPRINGER.
Hernandez, A. F., M. A. Bethel, G. L. Bakris, P. Merrill, S. M. Gustavson, B. G. Katona, P. Ohman, Y. Lokhnygina, R. J. Mentz, and R. R. Holman. “Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).” In DIABETOLOGIA, 61:S38–S38. SPRINGER, 2018.
Hernandez AF, Bethel MA, Bakris GL, Merrill P, Gustavson SM, Katona BG, et al. Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). In: DIABETOLOGIA. SPRINGER; 2018. p. S38–S38.
Hernandez, A. F., et al. “Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).” DIABETOLOGIA, vol. 61, SPRINGER, 2018, pp. S38–S38.
Hernandez AF, Bethel MA, Bakris GL, Merrill P, Gustavson SM, Katona BG, Ohman P, Lokhnygina Y, Mentz RJ, Holman RR. Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). DIABETOLOGIA. SPRINGER; 2018. p. S38–S38.
Published In
DIABETOLOGIA
EISSN
1432-0428
ISSN
0012-186X
Publication Date
October 1, 2018
Volume
61
Start / End Page
S38 / S38
Location
Berlin, GERMANY
Publisher
SPRINGER
Conference Name
54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
Related Subject Headings
- Endocrinology & Metabolism
- 4206 Public health
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences